Keyphrases
Mycobacterium Tuberculosis (M. tb)
100%
Plasmodium Falciparum
43%
Pyrrolone
37%
Structure-activity Relationship Studies
37%
Structure-activity Relationship
37%
Pks13
37%
Excellent Selectivity
34%
Rodent Models
34%
Mammalian Cell Lines
32%
Antimalarial Drugs
28%
Malaria
28%
Phenotypic Screening
28%
Mercapto
18%
Cytotoxicity Profile
18%
Spirocycles
18%
Optimization Study
18%
MmpL3 Inhibitor
18%
Relationship Mechanism
18%
Type II NADH Dehydrogenase
18%
Absorption Mechanism
18%
Sulfonamides
18%
EC50
18%
Absorption Distribution
18%
Indazole
18%
Ether
18%
TDRs
18%
Thioesterase
18%
Benzofuran
18%
Tropical Diseases
18%
Gene Profile
18%
Synthetase
18%
Chemical Inhibitors
18%
Metabolism
18%
Mechanism of Action
18%
Clinical Targets
18%
Drug Discovery
18%
IMPDH
18%
World Health Organization
18%
Compound Library
18%
Quinolones
18%
Preclinical Candidate
18%
Anti-tuberculosis
18%
Cysteine
18%
Pentafluorophenyl
18%
Tuberculosis
17%
NDH-2
15%
In Vitro Antimalarial Activity
15%
Lipophilic
14%
Physicochemical Properties
14%
MmpL3
14%
Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Tuberculosis
93%
Antimalarial Agent
56%
Structure Activity Relationship
56%
Antimalarial Activity
28%
Plasmodium falciparum
24%
Quinazolinone Derivative
18%
Sulfonamide
18%
Indazole Derivative
18%
Inosinate Dehydrogenase
18%
Cysteine
18%
Ion Channel
18%
Oxidoreductase
18%
Synthetase
18%
Cytotoxicity
18%
EC50
15%
Coenzyme A
10%
Pyrimethamine
9%
Piperidine
9%
Zwitterion
9%
Chloroquine
9%
Parasitemia
9%
Pyrazole
9%
Isotopes of Potassium
9%
Pharmaceutical Chemistry
9%
Infection
9%
Guanine
7%
Drug Discovery
6%
Adenosine Triphosphate
6%
Tropical Disease
6%
Pharmacokinetics
5%